Bone mineral density as an individual prognostic biomarker in patients with surgically-treated brain metastasis from lung cancer (nsclc)

HIGHLIGHTS

  • who: Inja Ilic and colleagues from the Department of Neurosurgery, University Hospital Bonn, Bonn, Germany have published the article: Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC), in the Journal: Cancers 2022, 14, 4633. of /2022/
  • what: This study investigated the prognostic value of BMD on overall survival (OS) of 95 patients with surgically-treated BM related to All patients were treated in a large tertiary care neuro-oncological center between 2013 and 2018.
  • how: The authors used only the transverse plane . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?